Stay updated on Tucidinostat & Tislelizumab in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Tucidinostat & Tislelizumab in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tucidinostat & Tislelizumab in NSCLC Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    A new entry Revision: v3.3.3 was added to the record history. The HHS Vulnerability Disclosure and the older Revision: v3.3.2 were removed from the footer.
    Difference
    0.2%
    Check dated 2025-12-23T08:19:18.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    31 days ago
    Change Detected
    Summary
    A minor revision entry (v3.3.2) was added and v3.2.0 was removed from the revision history. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T21:08:35.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    The page no longer shows the government funding/operating status notice. The banner warning about updates and operating status may no longer appear on the record history page.
    Difference
    0.8%
    Check dated 2025-11-17T18:32:37.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    Two updates to the recruitment status are recorded on the study record: 2023-02-13 and 2024-08-06.
    Difference
    0.1%
    Check dated 2025-11-03T13:06:21.000Z thumbnail image
  7. Check
    82 days ago
    Change Detected
    Summary
    Updated core content to reflect a new version (v3.2.0) and a government funding-related operating-status notice; the previous version tag (v3.1.0) was removed.
    Difference
    13%
    Check dated 2025-10-05T17:38:09.000Z thumbnail image
  8. Check
    89 days ago
    Change Detected
    Summary
    Version bump from v3.0.2 to v3.1.0; no other content changes detected.
    Difference
    0.3%
    Check dated 2025-09-28T10:50:51.000Z thumbnail image

Stay in the know with updates to Tucidinostat & Tislelizumab in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tucidinostat & Tislelizumab in NSCLC Clinical Trial page.